source
- Smaller biotech firms face uncertainty over U.S. tariff exemptions as new import taxes take effectA broad 100% tariff on imported pharmaceuticals introduced at the end of September under the Trump administration has created confusion for many biotech companies. While large drugmakers can use e…
- Congressional Bill Aims to End Arbitration in No Surprises Act, Shifting Payments to Median In-Network RatesRep. Frank Pallone introduced the Lower Premiums, Faster Payments Act, which would eliminate the arbitration system used under the No Surprises Act and replace it with a payment model based on medi…